Ebola Death Toll Exceeds 4,000 in the Democratic Republic of Congo
Ongoing conflicts and resource shortages across the country have hampered the efforts of health teams, while the mortality rate was recorded at 48.4 percent.
The death toll from the rapidly spreading Ebola outbreak in the Democratic Republic of Congo has surpassed 4,000 due to conflicts and insufficient resources.
Current Balance Sheet of the Outbreak
According to the latest official data on the ongoing Ebola outbreak in the Democratic Republic of Congo, a total of 8,300 cases have been detected and 4,018 people have lost their lives. While it was reported that 2,162 people who contracted the disease have recovered, the mortality rate in the outbreak stands at 48.4 percent based on current data.
Situation in the North Kivu Region
In the northeastern province of North Kivu, six cases were detected and four of them died. The cases were reported to have been seen in areas controlled by the M23 group, which is stated to be supported by Rwanda, as announced by the group itself on Friday.
Impact of Conflicts on Health Operations
The outbreak, which started in Ituri province, has spread to a total of seven provinces in the north and east of the country. The response efforts of health teams are severely hampered by armed conflicts in the region as well as a lack of trust in authorities in some areas.
Facility Attacks and Displacements
While conflicts between local militia groups in Ituri disrupted operations, more than 5,000 people were displaced, according to United Nations data. In the same province on Tuesday, a transit center holding Ebola patients was also burned down during unrest.
International Visits and Financial Support
French Foreign Minister Jean-Noël Barrot was expected to visit Bunia, the capital of Ituri, on Friday to demonstrate Paris's support. While France allocated 13.4 million euros to the fight between January and July, the US announced it would release an additional 237 million euros.
Vaccine and Treatment Efforts
Research on vaccine and treatment options against the Bundibugyo strain of the Ebola virus, which is held responsible for the current outbreak, is ongoing. The first doses of the Ervebo vaccine began to be administered to frontline volunteer personnel as part of ongoing clinical studies.